Syntheses and immunological effects of thymic humoral factor-γ2 and its Phe7-substituted analogues

Artificial Organs

Volumn 20, Issue 8, 1996, Pages 853-856

  Abiko, Takashi ^a,b   Sekino, Hiroshi ^a  

^a Kidney Research Laboratory   (Japan)

^b Kidney Research Laboratory   (Japan)

Author keywords

Impaired blastogenic response; Synthetic peptides; Uremic patients

Indexed keywords

AMINO ACIDS; PEPTIDES; SYNTHESIS (CHEMICAL);

IMMUNOLOGICAL EFFECTS; IMPAIRED BLASTOGENIC RESPONSE; INFECTIOUS DISEASE; PHYTOHAEMAGGLUTININ; SOLID-PHASE METHOD; SYNTHESIS EFFECTS; SYNTHESISED; SYNTHETIC PEPTIDE; T LYMPHOCYTES; UREMIC PATIENTS;

T-CELLS;

HUMORAL THYMUS FACTOR; HUMORAL THYMUS FACTOR DERIVATIVE; PHYTOHEMAGGLUTININ; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; DRUG SYNTHESIS; HUMAN; LYMPHOCYTE TRANSFORMATION; PRIORITY JOURNAL; T LYMPHOCYTE; UREMIA;

EID: 0029786945     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04558.x     Document Type: Article

References (9)

1. Burstein Y, Buchner V, pecht M, Trainin N. Biochemistry 1988;27:4066-71.
2. Dobbelstein H, Nephron 1979;17:409-14.
3. Linder A, Farewell UJ, Sherrerd DJ. Nephron 1981;27: 292-6.
4. Abiko T, Sekino H. Biotechnol. Thr. 1992;3:159-68.
5. Haw HD, du Vigneaud V. J Am Chem Soc 1960;82:4579-85.
6. Kaiser E, Colescott RL, Bossinger CD, Cook PI. Anal Biochem 1970;34:595-601.
7. Harris R, Ukaejiofo EU. Br J Haematol 1970;18:229-35.
8. Itoh Y, Kawai T. Rinsho Kensa 1983;27:928-32.
9. Fujii N, Otaka A, Ikemura O, Akaji K, Funakoshi S, Hayashi Y, Kuroda Y, Yajima H. J Chem Soc Commun 1987;274-78.